Skip to content
Visit the website
Organization profile · Continuous glucose monitoring

Lingo by Abbott

Upper-arm glucose biosensor and app · United Kingdom · direct UK shop

A 14-day continuous glucose biosensor and companion app designed to show how food, movement, sleep, and stress relate to glucose patterns.

UK plans
· ·
Sensor
Up to 14 days each
Reading
Interstitial glucose
Clinical care
Not included
Plans, compatibility and key details checkedReviewed

Who they are

Overview

Lingo is an Abbott-owned consumer product that pairs a 14-day continuous glucose biosensor with an app. The sensor streams interstitial glucose data each minute; the app connects those patterns to meals, activity, stress, and other logged events and turns them into trends, challenges, and a daily Lingo Count.

At a glance

The practical details to understand before comparing the current offer.

UK plans
· ·
Sensor
Up to 14 days each
Reading
Interstitial glucose
Clinical care
Not included

Company claims

  • Energy and cravings

    Lingo says its glucose feedback shows users how to fuel their bodies to minimize spikes, curb cravings and feel more energised and focused for longer.

  • Habits for reducing body fat

    Lingo says seeing real-time glucose data can help users build habits that reduce body fat.

Cost + payment

Pricing and access

Current UK plans

Two non-renewing plans and one auto-renewing subscription.

The plan price includes the listed sensors and app access. Confirm phone compatibility, delivery and current guarantee terms before purchase.

Plan type

The and plans do not auto-renew; the option is a subscription.

Market-specific

These prices and terms are for the UK offer; do not apply U.S. pricing, clearance or eligibility language to a UK purchase.

Start → result

How it works

Apply the sensor, pair it with a compatible phone, observe glucose patterns and use the app to test habits over the plan period.

  1. Apply

    Attach the biosensor to the back of the upper arm and pair it with a compatible phone.

  2. Observe

    Watch the glucose graph update and log food, activity, stress, and other events.

  3. Learn

    Use Lingo Count, trends, progress reports, and habit challenges to compare patterns over time.

What is measured

What Lingo measures and shows

The biosensor measures glucose in interstitial fluid and the app organizes the data into trends, scores and experiments.

  • Biosensor + app

    Measure

    minute-by-minute interstitial glucose · up to 14 days per sensor · Bluetooth streaming · no charging

    Choose a plan length based on how long you want to observe patterns; one sensor covers up to 14 days.

  • Biosensor + app

    Interpret

    real-time glucose graph · Lingo Count · weekly trends · progress reports

    Lingo Count and weekly trends summarize patterns in the app; they are not a clinician's interpretation.

  • Biosensor + app

    Experiment

    food and activity logging · stress and sleep context · habit challenges · educational content

    Use logs and challenges to compare food, activity, stress and sleep with your readings; do not use the app alone to make medical decisions.

Where + how to access

Availability and access

UK customers can buy directly from Lingo; plan terms and eligibility are market-specific.

Purchase
The three current plans are available through the first-party Lingo shop.
Eligibility
Confirm current suitability and market-specific warnings before buying.
Device
Not every phone is supported; check Abbott's current compatibility list.
Support
Product support, not clinical careProduct support
The app and replacement support do not include diagnosis, treatment or a clinician visit.

What the evidence shows

Evidence and limitations

Lingo is an Abbott product with regulatory and performance documentation. Evidence for routine CGM use among people without diabetes remains incomplete and should be separated from product usability.

What is established

  • Abbott's UK pages list three plan prices, up to 14 days per sensor, minute-by-minute app data, subscription terms and product support.

  • The FDA database confirms over-the-counter clearance for the U.S. Lingo system. Peer-reviewed reviews show that CGMs can reveal glucose patterns, but evidence of lasting health or behavior change in people without diabetes remains limited. Clearance does not validate every in-app coaching claim.

What remains uncertain

  • CGM can display glucose patterns, but expert and systematic reviews describe consumer use in people without diabetes as an emerging field with limited evidence for durable clinical benefit. Abbott's surveys and app metrics are company data, and FDA clearance of the U.S. system does not prove that Lingo prevents diabetes, causes weight loss, or improves long-term outcomes.

  • Abbott's current cross-market release describes Lingo for adults 18 or older who are not using insulin and says it is not intended to diagnose diseases, including diabetes. Users should not make medication, diet, or exercise changes solely from app readings, and people with an eating-disorder history should consult a healthcare professional. UK-specific suitability and phone compatibility still need checking before purchase.

Reporting + company history

News and company history

News coverage provides outside context, while company announcements document launches and milestones.

Independent reporting and context

Reporting covers regulatory clearance, launch and consumer experience. U.S. coverage does not establish the UK product's exact terms or classification.

Company and partner announcements

Company announcements document launches and milestones; they do not independently establish health benefit.

Decision guide

Eligibility and readings

Eligibility

Eligibility

Abbott's current cross-market materials describe Lingo for people 18 or older who are not using insulin. Confirm UK-specific suitability and device compatibility before buying.

Evidence boundary

Understanding sensor readings

Consumer CGM data can be informative but is not a diagnosis. Individual sensors can disagree, interstitial readings differ from direct blood measurements, and interpretation for people without diabetes is still evolving.

Common questions

Frequently asked questions

Transparency

Transparency and sources

Researched by Longevity.io

Reviewed

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.

Keep exploring

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint